Mingjie Luo

813 total citations · 1 hit paper
28 papers, 322 citations indexed

About

Mingjie Luo is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Mingjie Luo has authored 28 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Mingjie Luo's work include Asthma and respiratory diseases (5 papers), Retinal Imaging and Analysis (3 papers) and Peptidase Inhibition and Analysis (3 papers). Mingjie Luo is often cited by papers focused on Asthma and respiratory diseases (5 papers), Retinal Imaging and Analysis (3 papers) and Peptidase Inhibition and Analysis (3 papers). Mingjie Luo collaborates with scholars based in China, United States and United Kingdom. Mingjie Luo's co-authors include Yanfei Jin, Xu Tian, María Herrera, Li-Juan Yi, Jianghua Liu, Shan‐Shan Rao, Yiyi Wang, Hao Yin, Fei Yang and Zun Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Science Advances.

In The Last Decade

Mingjie Luo

27 papers receiving 319 citations

Hit Papers

Glucocorticoid-induced loss of beneficial gut bacterial e... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjie Luo China 9 149 78 37 37 33 28 322
Anna Damanaki Germany 16 146 1.0× 35 0.4× 69 1.9× 17 0.5× 6 0.2× 32 532
Marcelo Mattos United States 7 231 1.6× 44 0.6× 103 2.8× 36 1.0× 16 0.5× 8 594
M. Stavropoulos United States 7 71 0.5× 32 0.4× 37 1.0× 11 0.3× 12 0.4× 9 354
Keiichi Takigawa Japan 10 82 0.6× 31 0.4× 44 1.2× 12 0.3× 20 0.6× 19 330
Susanne Maurer Germany 10 106 0.7× 34 0.4× 9 0.2× 14 0.4× 11 0.3× 19 399
Christopher Powala United States 7 28 0.2× 23 0.3× 34 0.9× 14 0.4× 31 0.9× 11 416
R. de Lucas Spain 15 117 0.8× 36 0.5× 58 1.6× 12 0.3× 28 0.8× 60 614
Ito A Japan 11 79 0.5× 18 0.2× 23 0.6× 25 0.7× 14 0.4× 68 340
Vivian Cristina Noronha Novaes Brazil 12 45 0.3× 43 0.6× 31 0.8× 15 0.4× 7 0.2× 23 321
Juliana Dias Lourenço Brazil 13 92 0.6× 29 0.4× 126 3.4× 13 0.4× 16 0.5× 21 448

Countries citing papers authored by Mingjie Luo

Since Specialization
Citations

This map shows the geographic impact of Mingjie Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjie Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjie Luo more than expected).

Fields of papers citing papers by Mingjie Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjie Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjie Luo. The network helps show where Mingjie Luo may publish in the future.

Co-authorship network of co-authors of Mingjie Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjie Luo. A scholar is included among the top collaborators of Mingjie Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjie Luo. Mingjie Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Zhuanglin, et al.. (2025). Understanding the role of electric vehicle perception in shaping EV adoption intention. Transport Policy. 164. 255–264. 1 indexed citations
2.
Zhang, Liping, Mingjie Luo, Yu Cheng, et al.. (2025). Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer. Cell Death and Disease. 16(1). 170–170. 3 indexed citations
3.
Luo, Mingjie, Yahan Yang, Kang Xu, et al.. (2025). A large language model digital patient system enhances ophthalmology history taking skills. npj Digital Medicine. 8(1). 502–502. 1 indexed citations
4.
Yang, Yahan, Ruixin Wang, Yu‐Chun Lin, et al.. (2025). Current status and solutions for AI ethics in ophthalmology: a bibliometric analysis. npj Digital Medicine. 8(1). 594–594.
5.
Feng, Xiaoru, Mingjie Luo, Qi He, et al.. (2024). Latest developments of generative artificial intelligence and applications in ophthalmology. Asia-Pacific Journal of Ophthalmology. 13(4). 100090–100090. 3 indexed citations
6.
Zhang, Ping, Mingjie Luo, Guomin Xie, et al.. (2023). Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer. SHILAP Revista de lepidopterología. 6(3). 245–254. 8 indexed citations
7.
Zhou, Yuanfeng, Benjamin M. Parsons, Danni Sun, et al.. (2023). Efficacy of HS-10382 (TERN-701) in tumor xenograft models, a new investigational allosteric ABL1 kinase inhibitor as a potential treatment for CML. Journal of Pharmacology and Experimental Therapeutics. 385. 116–116. 1 indexed citations
8.
Chen, Chun‐Yuan, Shan‐Shan Rao, Tao Yue, et al.. (2022). Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis. Science Advances. 8(15). eabg8335–eabg8335. 118 indexed citations breakdown →
10.
Luo, Mingjie, Kaini Shen, Yangzhong Zhou, et al.. (2022). Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis. Experimental Hematology and Oncology. 11(1). 46–46. 19 indexed citations
11.
Huang, Bowen, Jianzhou Liu, Jun Lü, et al.. (2022). Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer. Frontiers in Oncology. 11. 812785–812785. 7 indexed citations
12.
Meng, Jianfeng & Mingjie Luo. (2021). CRABP2 involvement in a mechanism of Golgi stress and tumor dry matter in non-small cell lung cancer cells via ER dependent Hippo pathway. Acta Biochimica Polonica. 69(1). 31–36. 4 indexed citations
14.
Meng, Jianfeng, Mingjie Luo, & Haibin Li. (2021). Correlation between Plasma Cellular Retinoic Acid-Binding Protein 2 and Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells. Critical Reviews in Eukaryotic Gene Expression. 31(3). 81–89. 3 indexed citations
15.
Jiang, Xiaohong, et al.. (2020). One-Week Nebulization of Mycobacterium vaccae Can Protect Against Pulmonary Respiratory Syncytial Virus Infection in Balb/c Mice. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(5). 249–257. 2 indexed citations
16.
Jiang, Xiaohong, et al.. (2020). Inhalation of nebulized Mycobacterium vaccae can protect against allergic bronchial asthma in mice by regulating the TGF-β/Smad signal transduction pathway. Allergy Asthma and Clinical Immunology. 16(1). 59–59. 6 indexed citations
17.
Ma, Zhuanglin, et al.. (2020). Analyzing drivers’ perceived service quality of variable message signs (VMS). PLoS ONE. 15(10). e0239394–e0239394. 3 indexed citations
18.
Luo, Mingjie, Michelle Palmieri, Chris Riffkin, et al.. (2020). Defining the susceptibility of colorectal cancers to BH3-mimetic compounds. Cell Death and Disease. 11(9). 735–735. 13 indexed citations
19.
Meng, Jianfeng, Hua Li, Mingjie Luo, & Haibin Li. (2019). Efficacy of tiotropium in treating patients with moderate-to-severe asthma. Medicine. 98(33). e16637–e16637. 6 indexed citations
20.
Li, Chaoqian, et al.. (2016). Mycobacterium vaccae Nebulization Can Protect against Asthma in Balb/c Mice by Regulating Th9 Expression. PLoS ONE. 11(8). e0161164–e0161164. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026